Insulet Gross Profit 2010-2025 | PODD

Insulet annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Insulet gross profit for the quarter ending March 31, 2025 was $409M, a 33.31% increase year-over-year.
  • Insulet gross profit for the twelve months ending March 31, 2025 was $1.548B, a 26.24% increase year-over-year.
  • Insulet annual gross profit for 2024 was $1.446B, a 24.64% increase from 2023.
  • Insulet annual gross profit for 2023 was $1.16B, a 43.98% increase from 2022.
  • Insulet annual gross profit for 2022 was $0.806B, a 7.11% increase from 2021.
Insulet Annual Gross Profit
(Millions of US $)
2024 $1,446
2023 $1,160
2022 $806
2021 $752
2020 $582
2019 $480
2018 $370
2017 $277
2016 $211
2015 $133
2014 $127
2013 $112
2012 $92
2011 $67
2010 $44
2009 $18
Insulet Quarterly Gross Profit
(Millions of US $)
2025-03-31 $409
2024-12-31 $431
2024-09-30 $377
2024-06-30 $331
2024-03-31 $307
2023-12-31 $361
2023-09-30 $293
2023-06-30 $265
2023-03-31 $241
2022-12-31 $217
2022-09-30 $188
2022-06-30 $190
2022-03-31 $210
2021-12-31 $213
2021-09-30 $189
2021-06-30 $183
2021-03-31 $168
2020-12-31 $161
2020-09-30 $152
2020-06-30 $143
2020-03-31 $127
2019-12-31 $134
2019-09-30 $123
2019-06-30 $116
2019-03-31 $107
2018-12-31 $110
2018-09-30 $102
2018-06-30 $82
2018-03-31 $76
2017-12-31 $80
2017-09-30 $74
2017-06-30 $65
2017-03-31 $59
2016-12-31 $61
2016-09-30 $56
2016-06-30 $50
2016-03-31 $44
2015-12-31 $42
2015-09-30 $32
2015-06-30 $31
2015-03-31 $29
2014-12-31 $21
2014-09-30 $38
2014-06-30 $36
2014-03-31 $33
2013-12-31 $33
2013-09-30 $27
2013-06-30 $27
2013-03-31 $25
2012-12-31 $25
2012-09-30 $24
2012-06-30 $22
2012-03-31 $20
2011-12-31 $20
2011-09-30 $19
2011-06-30 $15
2011-03-31 $14
2010-12-31 $14
2010-09-30 $12
2010-06-30 $10
2010-03-31 $8
2009-12-31 $7
2009-09-30 $6
2009-06-30 $3
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $20.930B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.442B 27.95
Boston Scientific (BSX) United States $153.655B 38.47
Stryker (SYK) United States $150.679B 31.51
EssilorLuxottica (ESLOY) France $135.238B 0.00
Medtronic (MDT) Ireland $114.659B 16.25
Lonza Group Ag (LZAGY) Switzerland $51.418B 0.00
Haleon (HLN) United Kingdom $45.416B 25.92
ResMed (RMD) United States $37.840B 28.42
Agilent Technologies (A) United States $35.272B 22.99
GE HealthCare Technologies (GEHC) United States $35.028B 16.63
Terumo (TRUMY) Japan $24.711B 32.10
Koninklijke Philips (PHG) Netherlands $23.746B 16.66
Zimmer Biomet Holdings (ZBH) United States $18.825B 12.09
Baxter (BAX) United States $15.241B 11.38
Smith & Nephew SNATS (SNN) United Kingdom $13.608B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $7.072B 24.61
Lantheus Holdings (LNTH) United States $5.800B 14.63
Prestige Consumer Healthcare (PBH) United States $3.832B 17.12
Haemonetics (HAE) United States $3.755B 17.10
Perrigo (PRGO) Ireland $3.749B 9.50
Envista Holdings (NVST) United States $3.512B 29.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.378B 24.91
QuidelOrtho (QDEL) United States $2.134B 14.67
LeMaitre Vascular (LMAT) United States $1.937B 43.31
AtriCure (ATRC) United States $1.587B 0.00
Acuren (TIC) United States $1.427B 0.00
Green Thumb Industries (GTBIF) United States $1.357B 30.52
AdaptHealth (AHCO) United States $1.275B 12.94
Phibro Animal Health (PAHC) United States $1.262B 16.14
Neogen (NEOG) United States $1.211B 15.50
BioLife Solutions (BLFS) United States $1.087B 0.00
InMode (INMD) Israel $0.960B 9.67
Curaleaf Holdings (CURLF) Canada $0.818B 0.00
Kestra Medical Technologies (KMTS) United States $0.780B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.736B 0.00
Tilray Brands (TLRY) Canada $0.641B 0.00
Owens & Minor (OMI) United States $0.640B 5.31
Evolus (EOLS) United States $0.627B 0.00
CeriBell (CBLL) United States $0.606B 0.00
Capricor Therapeutics (CAPR) United States $0.521B 0.00
Valneva SE (VALN) France $0.511B 0.00
Surmodics (SRDX) United States $0.444B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.352B 12.94
Cresco Labs (CRLBF) United States $0.342B 0.00
Sanuwave Health (SNWV) United States $0.307B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Cerus (CERS) United States $0.296B 0.00
Quanterix (QTRX) United States $0.292B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.273B 0.00
Aurora Cannabis (ACB) Canada $0.264B 78.17
ZimVie (ZIMV) United States $0.262B 11.90
Brainsway (BWAY) Israel $0.239B 63.17
Biote (BTMD) United States $0.230B 6.48
OraSure Technologies (OSUR) United States $0.228B 0.00
Verano Holdings (VRNOF) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.219B 0.00
Omeros (OMER) United States $0.203B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.194B 0.00
TriSalus Life Sciences (TLSI) United States $0.189B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.14
Vireo Growth (VREOF) United States $0.164B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.124B 15.25
TerrAscend (TSNDF) Canada $0.115B 0.00
Fonar (FONR) United States $0.100B 12.91
MacroGenics (MGNX) United States $0.100B 0.00
Jushi Holdings (JUSHF) United States $0.098B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.085B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
InterCure (INCR) Israel $0.073B 0.00
Cytosorbents (CTSO) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
Zynex (ZYXI) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.57
United-Guardian (UG) United States $0.038B 13.02
Safety Shot (SHOT) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Senestech (SNES) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00